ESC Premium Access

Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator

Presentation

About the speaker

Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)
0 follower

23 more presentations in this session

Left atrial dysfunction still exists in patients who obtain normal left atrial volume after successful ablation of atrial fibrillation.

Speaker: Doctor H. Kawakami (Toon, JP)

Thumbnail

Same day discharge after atrial fibrillation ablation is feasible and safe. Results of a prospective study in 1015 patients

Speaker: Mr M. Viezelis (Kaunas, LT)

Thumbnail

Benefits of early intervention with catheter ablation in patients with atrial fibrillation

Speaker: Doctor S. Mohanty (Austin, US)

Thumbnail

Cryoballoon ablation of atrial fibrillation in low and medium volume hospitals - experiences of the German REGIONAL registry

Speaker: Doctor J. Michaelsen (Lingen, DE)

Thumbnail

Accuracy comparison of the new and previous Kodex occlusion tool software versions to assess pulmonary vein occlusion in atrial fibrillation cryoablation

Speaker: Doctor M. Polselli (Rome, IT)

Thumbnail

Access the full session

Congress committee e-posters choice in arrhythmias and device therapy

Speakers: Doctor M. Nakano, Doctor H. Kawakami, Mr M. Viezelis, Doctor S. Mohanty, Doctor J. Michaelsen...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

When is ablation the preferred approach to treat atrial fibrillation?

27 August 2021

This platform is supported by

logo Novo Nordisk